ProCE Banner Activity

Disease Overview and Role of Targeted Treatment in NF1-Associated Inoperable Plexiform Neurofibromas

Slideset Download
Download these slides from a live symposium for the latest evidence on targeted therapy in the management of inoperable plexiform neurofibromas in patients with NF1.

Released: June 20, 2022

Expiration: June 19, 2023

No longer available for credit.

Share

Faculty

Miriam Bornhorst

Miriam Bornhorst, MD

Clinical Director 
Gilbert Neurofibromatosis Clinic
Medical Director 
Cancer Genetics Clinic
Attending Neuro-oncologist
Department of Neurology and Oncology
Center for Genetics Medicine Research
Children's National Hospital
Assistant Professor of Pediatrics
George Washington University
Washington, D.C.

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Alexion Pharmaceuticals

Faculty Disclosure

Primary Author

Miriam Bornhorst, MD

Clinical Director 
Gilbert Neurofibromatosis Clinic
Medical Director 
Cancer Genetics Clinic
Attending Neuro-oncologist
Department of Neurology and Oncology
Center for Genetics Medicine Research
Children's National Hospital
Assistant Professor of Pediatrics
George Washington University
Washington, D.C.